DRW Securities’s Altimmune ALT Stock Holding History

DRW Securities’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,469	Closed	-$81.1K	–	1252
2025 Q4	$81.1K	Buy	+22,469	New	+$98K	﹤0.01%	1084
2024 Q3	–	Sell	-16,771	Closed	-$112K	–	555
2024 Q2	$112K	Buy	+16,771	New	+$124K	﹤0.01%	493

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

DRW Securities's ALT Position: Q1 2026 in Review

DRW Securities sold out of Altimmune (ALT) in Q1 2026, closing a stake of 22,469 shares — an estimated $81.1K sold.

DRW Securities first reported a position in ALT in Q2 2024 and held it in 2 quarters. The position peaked at $112K in Q2 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

DRW Securities reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 22,469 Altimmune shares in Q1 2026, an estimated $81.1K.
DRW Securities first reported a position in Altimmune in Q2 2024 and held it in 2 quarters.
DRW Securities's Altimmune position peaked at $112K in Q2 2024.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.